Material Type

• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Pathogen DNA (Derivative) (1)
• Plasma (double spun) (1)
• Plasma (single spun) (1)
• Saliva (1)
• Serum (3)
• Stool (2)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Not applicable (5)

Storage Temperature

• -35°C to -18°C (2)
• -85°C to -60°C (5)
• Liquid nitrogen (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (3)
• Followup records (3)
• Freezer temperature logs (3)
• Genomic datasets (2)
• Microbiological results (2)
• Participant Ethnicity (1)
• Pre-analytical data (1)
• Quality indicators (1)
• Survey data (3)
• Treatment records (3)

Timeframe

• 0 - 3 months (4)
• 3 - 6 months (2)
• > 6 months (2)

Participant Count

• 11 - 100 (5)

Sex

• Both sexes (5)

Age Range

• Infant (1 month - 2 years) (1)
• Young child (2 - 6 years) (1)
• Adolescent (12 - 18 years) (3)
• Young adult (18 - 40 years) (3)
• Adult (> 40 years) (3)

Biobank Services

• Cell culture (1)
• Molecular Extractions (1)
• Nucleic acid extraction (1)

Collection Type

• Case-control (2)
• Clinical Trial (1)
• Cross-sectional (3)
• Disease specific (1)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (5)
• No Genetic analysis restriction (3)
• No Human genetic analysis restriction (5)
• No restrictions (2)
• No Project specific restriction (4)
• No Scope of use restriction (5)

Collection Status

• Completed (3)
• In progress (2)
• Not-started (1)

Access Condition

• Open to applicants (3)
• Open only through collaboration (2)

Country

• Belgium (1)
• France (1)
• India (1)
• Kenya (1)
• United States (1)

County